You can do more to slow the progression of heart failure.
Wexler
Randy
R
Department of Family Medicine, The Ohio State University, Columbus, OH 43210, USA. randy.wexler@osumc.edu
Elton
Terry
T
Pleister
Adam
A
Feldman
David
D
D000465:Algorithms; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D004032:Diet; D019317:Evidence-Based Medicine; D015444:Exercise; D006333:Heart Failure / Q000175:diagnosis / Q000378:metabolism / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D045283:Natriuretic Agents / Q000097:blood; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D011379:Prognosis; D012680:Sensitivity and Specificity; D016540:Smoking Cessation; D016896:Treatment Outcome; D015431:Weight Loss
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D015415:Biomarkers; D045283:Natriuretic Agents; D020097:Natriuretic Peptide, Brain